SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001870062-24-000005
Filing Date
2024-01-16
Accepted
2024-01-16 16:37:18
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13G/A zeskind-2024schedule13game.htm SC 13G/A 49389
2 image_5.jpg GRAPHIC 90
  Complete submission text file 0001870062-24-000005.txt   50979
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Subject) CIK: 0001790340 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92766 | Film No.: 24535642
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O IMMUNEERING CORPORATION 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address
Zeskind Benjamin J. (Filed by) CIK: 0001870062 (see all company filings)

Type: SC 13G/A